← Leaderboards
Mark Stephen Diamond
University Of Pennsylvania
$625,239
Attributed
$625,239
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $208.4K · FY2019–21$250K$187.5K$125K$62.5K$0
'19
'20
'21
Funding mix
By agency
NIH$625,239 · 1
By mechanism
K08$625,239 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Stephen G Emerson$28,932,839
- Eli J Glatstein$647,800
- Lewis A Chodosh$38,386,361
- William F Degrado$44,950,833
- Serge Y Fuchs$17,647,204
Others in their field
Other Emerging Leaders on “Dendritic Cells”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Gary Fanger · Rise Therapeutics, Llc$11,457,164
- Norbert Pardi · University Of Pennsylvania$9,130,651
- Garcia-Sastre Adolfo · Icahn School Of Medicine At Mount Sinai$8,560,974
- Dawn C Ward · University Of California Los Angeles$7,282,377
- Kevin Wiehe · Duke University$7,046,198
Research focus
Dendritic CellsAntigen Presentation PathwayAntigensAdvisory CommitteesAreaBaseBasic ScienceCancer BurdenCancer EtiologyAgonistCancer TypeCareerCareer DevelopmentCd8-Positive T-LymphocytesCell LineCellular EngineeringChemokineColorectalCombination ImmunotherapyCombined Modality TherapyCommunitiesCross-PrimingDefined ContributionDevelopment Plans